K Number
K173678
Device Name
Diode Laser Cap
Date Cleared
2018-02-28

(90 days)

Product Code
Regulation Number
890.5500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Diode Laser Cap is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of Ila-V or females with androgenic alopecia who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.
Device Description
The COSMO-030 and COSMO-010 Diode Laser Cap is a dome-shaped low level laser therapy (LLLT) device designed to promote hair growth in women and men by exposing the entire scalp to the photobiostimulation of 272visible red light-emitting diodes at 650nm and 5mW each. The Cap is designed with an outer plastic cover and a protective inner (containing the electronics and laser array) and is powered by an included battery pack. The COSMO-020 Diode Laser Cap is exactly the same as the COSMO-030 with the exception of the number of diodes which is respective of model (148 diodes in COSMO-020).
More Information

None

No
The device description and performance studies focus on low-level laser therapy and electrical/EMC safety, with no mention of AI or ML technologies.

Yes
The device is indicated to "promote hair growth" for a medical condition (androgenic alopecia), which describes a therapeutic effect.

No.
The device description and intended use clearly state that the Diode Laser Cap is designed to promote hair growth through low-level laser therapy (LLLT), which is a treatment and not a diagnostic function.

No

The device description clearly states it is a "dome-shaped low level laser therapy (LLLT) device" with an "outer plastic cover and a protective inner (containing the electronics and laser array)" and is "powered by an included battery pack." This indicates it is a physical hardware device, not software only.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Function: The Diode Laser Cap is a therapeutic device that applies light energy directly to the scalp to stimulate hair growth. It does not analyze any biological samples.
  • Intended Use: The intended use is to promote hair growth, not to diagnose or monitor a condition based on in vitro analysis.
  • Device Description: The description clearly outlines a device that emits light and is applied externally. There is no mention of collecting or analyzing biological specimens.

Therefore, based on the provided information, the Diode Laser Cap falls under the category of a therapeutic device, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

Diode Laser Cap is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of IIa-V or females with androgenic alopecia who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.

Product codes (comma separated list FDA assigned to the subject device)

OAP

Device Description

The COSMO-030 and COSMO-010 Diode Laser Cap is a dome-shaped low level laser therapy (LLLT) device designed to promote hair growth in women and men by exposing the entire scalp to the photobiostimulation of 272visible red light-emitting diodes at 650nm and 5mW each. The Cap is designed with an outer plastic cover and a protective inner (containing the electronics and laser array) and is powered by an included battery pack. The COSMO-020 Diode Laser Cap is exactly the same as the COSMO-030 with the exception of the number of diodes which is respective of model (148 diodes in COSMO-020).

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

scalp

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The following performance data were provided in support of the substantial equivalence determination.

  1. Biocompatibility Testing
    The biocompatibility evaluation for the body-contacting components of the Diode Laser Cap was conducted in accordance with the "Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices –Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on June 16, 2016", as recognized by FDA. The battery of testing was performed to, and passed, including:
  • ISO 10993-5:2009/(R)2014, Biological Evaluation of Medical Devices –Par t 5: Tests for In Vitro Cytotoxicity
  • ISO 10993-10:2010. Biological Evaluation of Medical Devices -Par t 10: Tests for Irritation and Skin Sensitization
  1. Electrical and EMC Safety
    Electrical safety and EMC safety testing was performed to, and passed, the following standards:
  • IEC 60601-1 Medical electrical equipment -Part 1: General requirements for basic safety and essential performance
  • IEC 60601-1-11 Medical electrical equipment -Part 1-11: General requirements for basic safety and essential performance -Collateral standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment
  • IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility -Requirements and tests

In addition, testing to IEC 60825-1 certifies the laser system to classification 3R, which is the same as the predicate devices. And the charger conforms to IEC 60950 and the battery to IEC 62133.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K162071, K163170

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

None

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 890.5500 Infrared lamp.

(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

February 28, 2018

Cosmo Far East Technology Limited % Rain Yip Registered Engineer Feiying Drug & Medical Consulting Technical Service Group Rm. 3005, Area B, Bldg.1, Southward Ruifeng Business Center Guimiao Road Shenzhen, 518000 Cn

Re: K173678

Trade/Device Name: Diode Laser Cap Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared Lamp Regulatory Class: Class II Product Code: OAP Dated: November 21, 2017 Received: November 30, 2017

Dear Rain Yip:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

1

801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm_for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely, Jennifer R. Stevenson -

S3 For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known)

K173678

Device Name

Diode Laser Cap /(Model: COSMO-030, COSMO-020, COSMO-010)

Indications for Use (Describe)

Diode Laser Cap is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of Ila-V or females with androgenic alopecia who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.

Type of Use (Select one or both, as applicable)Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

"510(k) Summary" as required by 21 CFR Part 807.92.

Date: 2017.11.21

I. Submitter

Cosmo Far East Technology Limited Room 1504, Building 1, XingJiJia Yuan, Bao'an Avenue, Songgang, Bao'an District, Shenzhen, Guangdong, China

Tel.: +86 755 2321 0240 Tax: +86 755 2321 0240

Bob An (General Manager) Tel: +86 189 1115 3013 Email: cosmobeautylaser@126.com

II. Device

Type of 510(k): Traditional Common Name: Lamp, non-heating, for promotion of hair growth Trade Name: Diode Laser Cap Classification Name: Infrared lamp per 21 CFR 890.5500 Review Panel: General & Plastic Surgery Regulatory Class: II Product Code: OAP Regulation Number: 21 CFR 890.5500

III. Predicate Device

    1. Predicate device
ApplicantPredicate Device510(k) NumberApproval Date
EGlobal, LLCillumiflow Laser CapK162071Feb.24. 2017
Capillus, LLCCapillus laser domesK163170Jan.31, 2017
  1. Reference device: None

IV. Device Description

The COSMO-030 and COSMO-010 Diode Laser Cap is a dome-shaped low level laser therapy (LLLT) device designed to promote hair growth in women and men by exposing the entire scalp to the photobiostimulation of 272visible red light-emitting diodes at 650nm and 5mW each. The Cap is designed with an outer plastic cover and a protective inner (containing the electronics

4

and laser array) and is powered by an included battery pack. The COSMO-020 Diode Laser Cap is exactly the same as the COSMO-030 with the exception of the number of diodes which is respective of model (148 diodes in COSMO-020).

V. Indications for Use

Diode Laser Cap is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of IIa-V or females with androgenic alopecia who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.

VI. Comparison of Technological Characteristics With the Predicate Device

The Diode Laser Cap is substantially equivalent to the predicated device based on intended use, design, specifications and performance.

The Diode Laser Cap raises no safety or efficacy concerns when compared to the predicate devices.

Information for predicate device was obtained from publicly available sources, including the 510(k) Summary and device instruction manual. A technical comparison to the predicate is provided below:

| Comparison

ElementsSubject DevicePredicate Device 1Predicate Device 2
K NumberPendingK162071K161370
Trade nameDiode Laser Capillumiflow Laser CapCapillus laser domes
Classification nameInfrared LampInfrared LampInfrared Lamp
Product codeOAPOAPOAP
Intended
use/Indications
for
UseDiode Laser Cap is
indicated to promote
hair growth in males
with androgenic
alopecia who have
Norwood-Hamilton
classifications of
IIa~V or females with
androgenic alopecia
who have Ludwig-
Savin Classifications
of I~II and both with
Fitzpatrick Skin
Phototypes I to IV.The illumiflow Laser
Cap is indicated to
promote hair growth
in males with
androgenic alopecia
who have Norwood-
Hamilton
classifications of
IIa~V or females with
androgenic alopecia
who have Ludwig-
Savin Classifications
of I~II and both with
Fitzpatrick Skin
Phototypes I to IVThe Capillus laser
domes 82, 202, 272
Pro, 272 OfficePro,
302, 312, and 352, are
intended to treat
Androgenetic
Alopecia and promote
hair growth in males
who have Norwood
Hamilton
Classifications of IIa
to V patterns of hair
loss and to treat
Androgenetic
Alopecia and promote
hair growth in females
Comparison
ElementsSubject DevicePredicate Device 1Predicate Device 2
who have Ludwig
(Savin) Scale I-1 to I-
4, II-1, II-2, or frontal;
both with Fitzpatrick
Skin Types I to IV.
Location for useOTC applicationOTC applicationOTC application
Type of LightVisible red light-
emitting diodesVisible red light-
emitting diodesVisible red light-
emitting diodes
Wavelength650nm650nm650nm
Amount of laser
diodesCOSMO-010: 272
COSMO-020: 148
COSMO-030: 272272Capillus 82: 82
Capillus 202: 202
Capilus 272 Pro: 272
Energy of per laser
diode5mW5mW5mW
Classification
according
to
IEC60825-1Class 3RClass 3RClass 3R
Treatment timeEach treatment: 30min
16 weeks, every other
day (indefinite)Each treatment: 30min
16 weeks, every other
day (indefinite)Each treatment: 30min
17 weeks, every other
day (indefinite)
Applicable peopleNorwood-Hamilton
IIa~V (males)Norwood-Hamilton
IIa~V (males)Norwood-Hamilton
IIa~V (males)
Ludwig-Savin I~II
(females)Ludwig-Savin I~II
(females)Ludwig-Savin I~II or
frontal (females)
Applicable skinFitzpatrick Skin
Phototypes I-IVFitzpatrick Skin
Phototypes I-IVFitzpatrick Skin
Phototypes I-IV
Helmet/Cap designYesYesYes
Dimension(LWH)
COSMO-010:
23189cm
COSMO-020:
22189cm
COSMO-030:Perimeter: 61cm
Diameter: 19cmUnknown
Comparison
ElementsSubject DevicePredicate Device 1Predicate Device 2
22189cm
WeightCOSMO-010: 0.22kg
COSMO-020: 0.26kg
COSMO-030: 0.26kg0.22kgUnknown
Environment
for
operationTemperature: 10 °C
30°C (50°F86°F)
Humidity: 20%~80%Temperature: -10 °C
60°C (14°F140°F)
Humidity: 20%~80%Temperature: 5 °C
40°C (41°F104°F)
Humidity: 30%~80%
Environment
for
storageTemperature: -10 °C
60°C (14°F140°F)
Humidity: 20%~80%Temperature: -10 °C
60°C (14°F140°F)
Humidity: 20%~80%Unknown
Safety featureComplied with
IEC60601-1,
IEC60601-1-11,
IEC60601-1-2 and
IEC60825-1
Complied with
IEC62133 (Battery
pack)
Complied with
IEC60950 (Adapter)Complied with
IEC60601-1,
IEC60601-1-2 and
IEC60825-1
Complied with
IEC62133 (Battery)
Complied with
IEC60950 (Charger)Complied with
IEC60825-1
Complied with
IEC60950 (Charger)
Biocompatibility
featureAll body-contacting
materials are complied
with ISO10993-5 and
ISO 10993-10.All body-contacting
materials are complied
with ISO10993-5 and
ISO 10993-10.All body-contacting
materials are complied
with ISO10993-5 and
ISO 10993-10.

5

6

VII.Performance Data

The following performance data were provided in support of the substantial equivalence determination.

1) Biocompatibility Testing

The biocompatibility evaluation for the body-contacting components of the Diode Laser Cap was conducted in accordance with the "Use of International Standard ISO 10993-1, "Biological

7

Evaluation of Medical Devices –Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on June 16, 2016", as recognized by FDA. The battery of testing was performed to, and passed, including:

  • ISO 10993-5:2009/(R)2014, Biological Evaluation of Medical Devices –Par t 5: Tests for In Vitro Cytotoxicity

  • ISO 10993-10:2010. Biological Evaluation of Medical Devices -Par t 10: Tests for Irritation and Skin Sensitization

2) Electrical and EMC Safety

Electrical safety and EMC safety testing was performed to, and passed, the following standards:

  • IEC 60601-1 Medical electrical equipment -Part 1: General requirements for basic safety and essential performance

  • IEC 60601-1-11 Medical electrical equipment -Part 1-11: General requirements for basic safety and essential performance -Collateral standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment

  • IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility -Requirements and tests

In addition, testing to IEC 60825-1 certifies the laser system to classification 3R, which is the same as the predicate devices. And the charger conforms to IEC 60950 and the battery to IEC 62133.

Summary

Based on the above performance as documented in this application, Diode Laser Cap was found to have a safety and effectiveness profile that is similar to the predicate device.

VIII. Conclusions

In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the comparison of intended use, design, materials and performance, the Diode Laser Cap is to be concluded substantial equivalent to its predicate devices.